Table 1.
Characteristics of study population by group
| Characteristic | HR (n = 16) | RFA (n = 55) | LT (n = 23) | Total (n = 94) | P - value |
|---|---|---|---|---|---|
| Age (years) (mean ± SD) | 58.6 ± 8.3 | 65.4 ± 10.8 | 54.3 ± 6.2 | 62 ± 11 | < 0.001*,† |
| Male (%) | 13 (81.3%) | 37 (67.3%) | 21 (91.3%) | 71 (76%) | 0.067 |
| Cirrhosis (%) | 12 (75%) | 51 (91.1%) | 23 (100%) | 86 (91%) | 0.020‡ |
| HBV (%) | 6 (37.5%) | 15 (27.3%) | 8 (34.8%) | 29 (31%) | 0.661 |
| HCV (%) | 7 (43.8%) | 31 (56.4%) | 14 (60.1%) | 52 (55%) | 0.555 |
| Diabetic (%) | 1 (6.3%) | 16 (29.1%) | 4 (17.4%) | 21 (22%) | 0.125 |
| BMI (mean ± SD) | 22.7 ± 3.3 | 25.4 ± 5.5 | 29.4 ± 4.9 | 26 ± 6 | < 0.001‡, † |
| Ascites (%) | 0 (0%) | 18 (32.7%) | 8 (34.8%) | 26 (28%) | 0.025*,‡ |
| Serum bilirubin (mg/dL) (mean ± SD) | 1.1 ± 0.7 | 1.5 ± 1.0 | 1.8 ± 1.1 | 1.5 ± 1 | 0.097 |
| MELD score (mean ± SD) | 8 ± 2 | 11 ± 4 | 11 ± 4 | 11 ± 4 | 0.016*,‡ |
| Platelet count (x103/μL)(mean ± SD) | 139 ± 46 | 119 ± 69 | 109 ± 76 | 121 ± 69 | 0.394 |
| Tumor size (cm) (mean ± SD) | 2.0 ± 0.6 | 2.3 ± 0.5 | 2.3 ± 0.5 | 2.3 ± 0.5 | 0.114 |
SD: standard deviation; HBV: Hepatitis B virus; HCV: Hepatitis C virus; BMI: body mass index;
*
P -value of HR vs. RFA < 0.05;
†
P -value of RFA vs. LT < 0.05;
‡
P - value of HR vs. LT < 0.05